According to TELA Bio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.90641. At the end of 2023 the company had a P/S ratio of 2.77.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.77 | -47.86% |
2022 | 5.32 | -15.57% |
2021 | 6.30 | -47.13% |
2020 | 11.9 | 24.63% |
2019 | 9.56 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Merit Medical MMSI | 3.47 | 81.89% | ๐บ๐ธ USA |
Inari Medical
NARI | 4.46 | 133.74% | ๐บ๐ธ USA |